13F

HCA HCA HEALTHCARE INC

2026Q1 · CUSIP 40412C101 · Sector: Healthcare & Biotech

Cooling · Breadth rolling over
Holders
1,404
Δ holders QoQ
+14
Breadth percentile
Top 22%
Whale holders
320
Δ whales
-5
Inst. holding value
$60.5B
New positions
149
Closed positions
135
Price momentum (1Q)
-20.8%
Put / Call
29/28

Breadth history (34 quarters)

2018Q1: Δ+51 · h=600 2018Q2: Δ+29 · h=629 2018Q3: Δ+8 · h=637 2018Q4: Δ+44 · h=681 2019Q1: Δ+2 · h=683 2019Q2: Δ-25 · h=658 2019Q3: Δ+10 · h=668 2019Q4: Δ+32 · h=700 2020Q1: Δ-5 · h=695 2020Q2: Δ-22 · h=673 2020Q3: Δ+34 · h=707 2020Q4: Δ+57 · h=764 2021Q1: Δ+6 · h=770 2021Q2: Δ+39 · h=809 2021Q3: Δ+64 · h=873 2021Q4: Δ+64 · h=937 2022Q1: Δ+27 · h=964 2022Q2: Δ-85 · h=879 2022Q3: Δ-17 · h=862 2022Q4: Δ+89 · h=951 2023Q1: Δ+14 · h=965 2023Q2: Δ+41 · h=1006 2023Q3: Δ-13 · h=993 2023Q4: Δ+59 · h=1052 2024Q1: Δ+69 · h=1121 2024Q2: Δ+31 · h=1152 2024Q3: Δ+45 · h=1197 2024Q4: Δ-22 · h=1175 2025Q1: Δ+44 · h=1219 2025Q2: Δ+21 · h=1240 2025Q3: Δ+40 · h=1280 2025Q4: Δ+110 · h=1390 2026Q1: Δ+14 · h=1404 2018Q1: holders=600 2018Q2: holders=629 2018Q3: holders=637 2018Q4: holders=681 2019Q1: holders=683 2019Q2: holders=658 2019Q3: holders=668 2019Q4: holders=700 2020Q1: holders=695 2020Q2: holders=673 2020Q3: holders=707 2020Q4: holders=764 2021Q1: holders=770 2021Q2: holders=809 2021Q3: holders=873 2021Q4: holders=937 2022Q1: holders=964 2022Q2: holders=879 2022Q3: holders=862 2022Q4: holders=951 2023Q1: holders=965 2023Q2: holders=1006 2023Q3: holders=993 2023Q4: holders=1052 2024Q1: holders=1121 2024Q2: holders=1152 2024Q3: holders=1197 2024Q4: holders=1175 2025Q1: holders=1219 2025Q2: holders=1240 2025Q3: holders=1280 2025Q4: holders=1390 2026Q1: holders=1404 -110 -55 +0 +55 +110 54010081475 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 22 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 3% -20.8%
2025Q3 Top 6% +11.0% -16.6%
2025Q2 Top 15% +20.3% +36.4%
2025Q1 Top 3% +4.3% +23.8%
2024Q3 Top 5% -5.6% +12.6%
2024Q2 Top 7% -7.4% -13.9%
2024Q1 Top 2% +16.1% +6.6%
2023Q4 Top 8% +4.9% +21.8%

Options Sentiment

Put holders
29
QoQ: 0
Call holders
28
QoQ: +1

See methodology →

Fundamentals

PE (TTM)
12.5
EPS (TTM)
$29.03
EPS YoY
+28.9%
Revenue (TTM)
$76.4B
Revenue YoY
+6.7%
Quarterly Revenue & EPS (4Y)
2022-06-30: $14.8B 2022-09-30: $15.0B 2022-12-31: $15.5B 2023-03-31: $15.6B 2023-06-30: $15.9B 2023-09-30: $16.2B 2023-12-31: $17.3B 2024-03-31: $17.3B 2024-06-30: $17.5B 2024-09-30: $17.5B 2024-12-31: $18.3B 2025-03-31: $18.3B 2025-06-30: $18.6B 2025-09-30: $19.2B 2025-12-31: $19.5B 2026-03-31: $19.1B 2022-06-30: EPS 3.90 2022-09-30: EPS 3.91 2022-12-31: EPS 7.20 2023-03-31: EPS 4.85 2023-06-30: EPS 4.29 2023-09-30: EPS 3.91 2023-12-31: EPS 5.92 2024-03-31: EPS 5.93 2024-06-30: EPS 5.53 2024-09-30: EPS 4.88 2024-12-31: EPS 5.66 2025-03-31: EPS 6.45 2025-06-30: EPS 6.83 2025-09-30: EPS 6.96 2025-12-31: EPS 8.09 2026-03-31: EPS 7.15 0B 9.8B 19.5B $B 0.00 4.45 8.90 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 16 2023-03-31: PE 13.52023-06-30: PE 12.92023-09-30: PE 11.62023-12-31: PE 162024-03-31: PE 15.82024-06-30: PE 17.32024-09-30: PE 15.22024-12-31: PE 14.22025-03-31: PE 17.12025-06-30: PE 16.52025-09-30: PE 18.22025-12-31: PE 192026-03-31: PE 14.5 10 15 20 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)